Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension

Cellular Physiology and Biochemistry

Volumn 37, Issue 5, 2015, Pages 1712-1724

  Sun, Wuzhuang ^a   Jiang, Xue ^a   Yuan, Lindong ^a   Li, Peng ^a   Wang, Jia ^a   Wang, Pengyu ^a   Zhang, Lihai ^a   Sun, Bojian ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Pulmonary artery hypertension; Serotonin; Simvastatin

Indexed keywords

CIGARETTE SMOKE; SEROTONIN; SEROTONIN TRANSPORTER; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ARTERY PRESSURE; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGHT VENTRICULAR HYPERTROPHY INDEX; SMALL ARTERY WALL AREA; SMALL ARTERY WALL THICKNESS; SMOKING; SMOOTH MUSCLE FIBER; UPREGULATION; WEIGHT REDUCTION; ANIMAL; BLOOD; BLOOD PRESSURE; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HYPERTENSION, PULMONARY; LUNG; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; MALE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIMVASTATIN; SMOKING;

EID: 84946771873     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438536     Document Type: Article

References (39)

1. McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller D P, Peacock AJ, Pepke-Zaba J, Pulido T, Rich S, Rosenkranz S, Suissa S, Humbert M: Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol 2013;62:D51-59.
2. Elliott CG: Genetics of pulmonary arterial hypertension. Clin Chest Med 2013;34:651-663.
3. El Chami H, Hassoun PM: Immune and inflammatory mechanisms in pulmonary arterial hypertension. Prog Cardiovasc Dis 2012;55:218-228.
4. Malenfant S, Neyron AS, Paulin R, Potus F, Meloche J, Provencher S, Bonnet S: Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ 2013;3:278-293.
5. Liu XR, Liu Q, Chen GY, Hu Y, Sham JS, Lin MJ: Down-regulation of TRPM8 in pulmonary arteries of pulmonary hypertensive rats. Cell Physiol Biochem 2013;31:892-904.
6. Chemla D, Humbert M, Sitbon O, Montani D, Herve P: Systolic and mean pulmonary artery pressures: are they interchangeable in patients with pulmonary hypertension? Chest 2015;147:943-950.
7. Lau EM, Humbert M, Celermajer DS: Early detection of pulmonary arterial hypertension. Nat Rev Cardiol 2015;12:143-155.
8. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF: Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009;297:L1013-1032.
9. Colvin KL, Yeager ME: Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease. J Pulm Respir Med 2014;4:198.
10. Yildiz O, Smith JR, Purdy RE: Serotonin and vasoconstrictor synergism. Life Sci 1998;62:1723-1732.
11. Fanburg BL, Lee SL: A new role for an old molecule: serotonin as a mitogen. Am J Physiol 1997;272:L795-806.
12. Robinson MJ, Cobb MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;9:180-186.
13. Lee SL, Wang WW, Fanburg BL: Association of Tyr phosphorylation of GTPase-activating protein with mitogenic action of serotonin. Am J Physiol 1997;272:C223-230.
14. Lee SL, Wang WW, Fanburg BL: Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Radic Biol Med 1998;24:855-858.
15. Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P, Simonneau G, Hamon M, Adnot S, Eddahibi S: Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 2004;94:1263-1270.
16. Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M, Adnot S: Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 2000;105:1555-1562.
17. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S: Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-1150.
18. Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40.
19. Kinlay S: Potential vascular benefits of statins. Am J Med 2005;118:62-67.
20. Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H, Patel S, Rosa R, Hermanowski-Vosatka A, Wang PR, Zhang D, Peterson L, Detmers PA, Chao YS, Wright SD: Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001;21:115-121.
21. Frenette PS: Locking a leukocyte integrin with statins. N Engl J Med 2001;345:1419-1421.
22. Schonbeck U, Libby P: Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 2004;109:II18-26.
23. Kao PN: Simvastatin treatment of pulmonary hypertension: an observational case series. Chest 2005;127:1446-1452.
24. Nishimura T, Faul JL, Berry GJ, Vaszar LT, Qiu D, Pearl RG, Kao PN: Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med 2002;166:1403-1408.
25. Scanlon SM, Williams DC, Schloss P: Membrane cholesterol modulates serotonin transporter activity. Biochemistry 2001;40:10507-10513.
26. MacLean MR, Herve P, Eddahibi S, Adnot S: 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 2000;131:161-168.
27. Wang Y, Jiang X, Zhang L, Wang L, Li Z, Sun W: Simvastatin mitigates functional and structural impairment of lung and right ventricle in a rat model of cigarette smoke-induced COPD. Int J Clin Exp Pathol 2014;7:8553-8562.
28. Kennedy-Feitosa E, Pinto RF, Pires KM, Monteiro AP, Machado MN, Santos JC, Ribeiro ML, Zin WA, Canetti CA, Romana-Souza B, Porto LC, Valenca SS: The influence of 5-lipoxygenase on cigarette smoke-induced emphysema in mice. Biochim Biophys Acta 2014;1840:199-208.
29. Givi ME, Peck MJ, Boon L, Mortaz E: The role of dendritic cells in the pathogenesis of cigarette smoke-induced emphysema in mice. Eur J Pharmacol 2013;721:259-266.
30. Crane-Godreau MA, Black CC, Giustini AJ, Dechen T, Ryu J, Jukosky JA, Lee HK, Bessette K, Ratcliffe NR, Hoopes PJ, Fiering S, Kelly JA, Leiter JC: Modeling the influence of vitamin D deficiency on cigarette smoke-induced emphysema. Front Physiol 2013;4:132.
31. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB: Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62:D42-50.
32. Hoshikawa Y, Nana-Sinkam P, Moore MD, Sotto-Santiago S, Phang T, Keith RL, Morris KG, Kondo T, Tuder RM, Voelkel NF, Geraci MW: Hypoxia induces different genes in the lungs of rats compared with mice. Physiol Genomics 2003;12:209-219.
33. Stenmark KR, Fagan KA, Frid MG: Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006;99:675-691.
34. Yao H, Edirisinghe I, Rajendrasozhan S, Yang SR, Caito S, Adenuga D, Rahman I: Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol 2008;294:L1174-1186.
35. Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS, Kim SE, Lee YS, Lee SD: Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005;172:987-993.
36. Peinado VI, Barbera JA, Abate P, Ramirez J, Roca J, Santos S, Rodriguez-Roisin R: Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1605-1611.
37. Maestrelli P, Saetta M, Mapp CE, Fabbri LM: Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:S76-80.
38. Laudi S, Trump S, Schmitz V, West J, McMurtry IF, Mutlak H, Christians U, Weimann J, Kaisers U, Steudel W: Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin. Am J Physiol Lung Cell Mol Physiol 2007;293:L630-638.
39. Kato T, Hashikabe H, Iwata C, Akimoto K, Hattori Y: Statin blocks Rho/Rho-kinase signalling and disrupts the actin cytoskeleton: relationship to enhancement of LPS-mediated nitric oxide synthesis in vascular smooth muscle cells. Biochim Biophys Acta 2004;1689:267-272.